BMRN logo

BioMarin Pharmaceutical Inc. (BMRN) Cash From Investing

Annual CFI:

$136.49M+$247.74M(+222.70%)
December 31, 2024

Summary

  • As of today, BMRN annual cash from investing is $136.49 million, with the most recent change of +$247.74 million (+222.70%) on December 31, 2024.
  • During the last 3 years, BMRN annual cash from investing has risen by +$502.80 million (+137.26%).
  • BMRN annual cash from investing is now -48.37% below its all-time high of $264.35 million, reached on December 31, 2018.

Performance

BMRN Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBMRNcash flow metrics

Quarterly CFI:

-$12.59M+$15.65M(+55.41%)
June 30, 2025

Summary

  • As of today, BMRN quarterly cash from investing is -$12.59 million, with the most recent change of +$15.65 million (+55.41%) on June 30, 2025.
  • Over the past year, BMRN quarterly cash from investing has dropped by -$103.07 million (-113.92%).
  • BMRN quarterly cash from investing is now -102.73% below its all-time high of $461.25 million, reached on December 31, 2014.

Performance

BMRN Quarterly Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBMRNcash flow metrics

TTM CFI:

$19.42M-$103.07M(-84.15%)
June 30, 2025

Summary

  • As of today, BMRN TTM cash from investing is $19.42 million, with the most recent change of -$103.07 million (-84.15%) on June 30, 2025.
  • Over the past year, BMRN TTM cash from investing has increased by +$53.94 million (+156.25%).
  • BMRN TTM cash from investing is now -95.91% below its all-time high of $474.86 million, reached on September 30, 2018.

Performance

BMRN TTM Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBMRNcash flow metrics

Cash From Investing Formula

CFI = Cash Inflows from Investments − Cash Outflows for Investments

BMRN Cash From Investing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year+222.7%-113.9%+156.3%
3Y3 Years+137.3%+57.6%+116.6%
5Y5 Years+539.9%+94.9%+117.1%

BMRN Cash From Investing Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Yearat high+137.3%-113.9%+80.6%-85.8%+114.1%
5Y5-Yearat high+137.3%-111.8%+89.5%-85.8%+105.3%
All-TimeAll-Time-48.4%+111.6%-102.7%+98.3%-95.9%+101.7%

BMRN Cash From Investing History

DateAnnualQuarterlyTTM
Jun 2025
-
-$12.59M(+55.4%)
$19.42M(-84.1%)
Mar 2025
-
-$28.24M(-137.0%)
$122.49M(-10.3%)
Dec 2024
$136.49M(+222.7%)
$76.40M(+572.9%)
$136.49M(+2899.2%)
Sep 2024
-
-$16.16M(-117.9%)
-$4.88M(+85.9%)
Jun 2024
-
$90.48M(+735.6%)
-$34.52M(+63.8%)
Mar 2024
-
-$14.24M(+78.1%)
-$95.47M(+14.2%)
Dec 2023
-$111.24M(-455.4%)
-$64.96M(-41.8%)
-$111.24M(-10.2%)
Sep 2023
-
-$45.80M(-255.1%)
-$100.99M(-28.5%)
Jun 2023
-
$29.53M(+198.4%)
-$78.59M(+43.0%)
Mar 2023
-
-$30.01M(+45.1%)
-$137.82M(-588.1%)
Dec 2022
-$20.03M(+94.5%)
-$54.71M(-133.8%)
-$20.03M(+3.4%)
Sep 2022
-
-$23.40M(+21.2%)
-$20.74M(+82.3%)
Jun 2022
-
-$29.70M(-133.8%)
-$117.19M(+43.6%)
Mar 2022
-
$87.78M(+258.4%)
-$207.74M(+43.3%)
Dec 2021
-$366.31M(-583.2%)
-$55.42M(+53.8%)
-$366.31M(-22.2%)
Sep 2021
-
-$119.85M(+0.3%)
-$299.87M(-309.0%)
Jun 2021
-
-$120.26M(-69.9%)
-$73.32M(+63.7%)
Mar 2021
-
-$70.79M(-742.0%)
-$201.81M(-276.4%)
Dec 2020
-$53.62M(-72.8%)
$11.03M(-89.7%)
-$53.62M(+52.8%)
Sep 2020
-
$106.70M(+142.9%)
-$113.54M(+33.8%)
Jun 2020
-
-$248.75M(-421.4%)
-$171.56M(-277.1%)
Mar 2020
-
$77.40M(+258.3%)
$96.86M(+412.2%)
Dec 2019
-$31.03M(-111.7%)
-$48.90M(-200.4%)
-$31.03M(+41.6%)
Sep 2019
-
$48.68M(+147.5%)
-$53.09M(-117.7%)
Jun 2019
-
$19.67M(+139.0%)
$300.56M(+5.2%)
Mar 2019
-
-$50.48M(+28.9%)
$285.61M(+8.0%)
Dec 2018
$264.35M(+186.5%)
-$70.96M(-117.6%)
$264.35M(-44.3%)
Sep 2018
-
$402.33M(+8420.2%)
$474.86M(+232.8%)
Jun 2018
-
$4.72M(+106.6%)
-$357.69M(+11.1%)
Mar 2018
-
-$71.73M(-151.4%)
-$402.24M(-31.7%)
Dec 2017
-$305.46M(+36.9%)
$139.55M(+132.4%)
-$305.46M(+59.5%)
Sep 2017
-
-$430.23M(-980.4%)
-$754.65M(-15.9%)
Jun 2017
-
-$39.82M(-259.0%)
-$651.36M(-21.5%)
Mar 2017
-
$25.05M(+108.1%)
-$536.00M(-10.7%)
Dec 2016
-$484.05M(+59.0%)
-$309.65M(+5.3%)
-$484.05M(-410.3%)
Sep 2016
-
-$326.94M(-532.8%)
-$94.85M(-156.1%)
Jun 2016
-
$75.54M(-1.9%)
$169.01M(+148.1%)
Mar 2016
-
$77.00M(-3.2%)
-$351.73M(+70.2%)
Dec 2015
-$1.18B(-706.3%)
$79.55M(+226.1%)
-$1.18B(-47.8%)
Sep 2015
-
-$63.08M(+85.8%)
-$797.90M(+13.5%)
Jun 2015
-
-$445.20M(+40.7%)
-$922.05M(-78.3%)
Mar 2015
-
-$750.87M(-262.8%)
-$517.22M(-365.8%)
Dec 2014
$194.56M(+165.1%)
$461.25M(+346.4%)
$194.56M(+133.9%)
Sep 2014
-
-$187.23M(-363.8%)
-$573.11M(-49.8%)
Jun 2014
-
-$40.37M(-3.3%)
-$382.57M(-16.0%)
Mar 2014
-
-$39.09M(+87.2%)
-$329.94M(-10.4%)
Dec 2013
-$298.78M(-52.7%)
-$306.42M(-9348.9%)
-$298.78M(-568.1%)
Sep 2013
-
$3.31M(-73.0%)
-$44.72M(+35.2%)
Jun 2013
-
$12.26M(+254.4%)
-$68.98M(+70.5%)
Mar 2013
-
-$7.94M(+84.8%)
-$233.62M(-19.4%)
Dec 2012
-$195.65M(-118.5%)
-$52.35M(-149.9%)
-$195.65M(-9.8%)
Sep 2012
-
-$20.95M(+86.3%)
-$178.21M(+17.3%)
Jun 2012
-
-$152.38M(-607.3%)
-$215.58M(-245.0%)
Mar 2012
-
$30.04M(+186.0%)
-$62.49M(+30.2%)
DateAnnualQuarterlyTTM
Dec 2011
-$89.56M(+11.6%)
-$34.91M(+40.1%)
-$89.56M(-31.2%)
Sep 2011
-
-$58.32M(-8360.8%)
-$68.26M(-389.6%)
Jun 2011
-
$706.00K(-76.2%)
-$13.94M(+49.8%)
Mar 2011
-
$2.97M(+121.8%)
-$27.77M(+72.6%)
Dec 2010
-$101.34M(-27.2%)
-$13.61M(-239.8%)
-$101.34M(+23.9%)
Sep 2010
-
-$4.00M(+69.5%)
-$133.25M(+22.6%)
Jun 2010
-
-$13.13M(+81.4%)
-$172.12M(-40.4%)
Mar 2010
-
-$70.60M(-55.1%)
-$122.58M(-53.9%)
Dec 2009
-$79.67M(-317.6%)
-$45.52M(-6.2%)
-$79.67M(+10.3%)
Sep 2009
-
-$42.87M(-217.8%)
-$88.85M(-184.5%)
Jun 2009
-
$36.40M(+231.5%)
-$31.23M(+78.9%)
Mar 2009
-
-$27.69M(+49.4%)
-$148.13M(-676.5%)
Dec 2008
-$19.08M(+87.4%)
-$54.70M(-470.8%)
-$19.08M(+42.6%)
Sep 2008
-
$14.75M(+118.3%)
-$33.23M(-176.3%)
Jun 2008
-
-$80.49M(-179.4%)
$43.56M(+155.0%)
Mar 2008
-
$101.36M(+247.2%)
-$79.24M(+47.5%)
Dec 2007
-$151.00M(+22.5%)
-$68.85M(-175.2%)
-$151.00M(+13.8%)
Sep 2007
-
$91.54M(+145.0%)
-$175.13M(+50.2%)
Jun 2007
-
-$203.29M(-786.7%)
-$351.32M(-99.6%)
Mar 2007
-
$29.60M(+131.8%)
-$176.00M(+9.6%)
Dec 2006
-$194.77M(-438.1%)
-$92.98M(-9.8%)
-$194.77M(-91.5%)
Sep 2006
-
-$84.65M(-202.7%)
-$101.69M(-623.6%)
Jun 2006
-
-$27.96M(-358.2%)
-$14.05M(-137.6%)
Mar 2006
-
$10.83M(>+9900.0%)
$37.37M(-35.1%)
Dec 2005
$57.60M(+476.7%)
$90.00K(-97.0%)
$57.60M(-12.0%)
Sep 2005
-
$2.99M(-87.3%)
$65.42M(-19.1%)
Jun 2005
-
$23.45M(-24.5%)
$80.91M(+199.0%)
Mar 2005
-
$31.07M(+292.7%)
$27.06M(+277.0%)
Dec 2004
-$15.29M(+70.0%)
$7.91M(-57.2%)
-$15.29M(+73.4%)
Sep 2004
-
$18.48M(+160.8%)
-$57.58M(+34.2%)
Jun 2004
-
-$30.40M(-169.5%)
-$87.50M(-9.9%)
Mar 2004
-
-$11.28M(+67.2%)
-$79.65M(-56.3%)
Dec 2003
-$50.95M(-171.9%)
-$34.38M(-200.3%)
-$50.95M(-399.2%)
Sep 2003
-
-$11.45M(+49.2%)
$17.03M(-63.2%)
Jun 2003
-
-$22.54M(-229.4%)
$46.31M(-37.5%)
Mar 2003
-
$17.42M(-48.2%)
$74.13M(+4.5%)
Dec 2002
$70.91M(+153.0%)
$33.60M(+88.5%)
$70.91M(+221.2%)
Sep 2002
-
$17.83M(+237.5%)
-$58.53M(+30.3%)
Jun 2002
-
$5.28M(-62.8%)
-$83.95M(+35.8%)
Mar 2002
-
$14.20M(+114.8%)
-$130.81M(+2.3%)
Dec 2001
-$133.91M(-8517.4%)
-$95.84M(-1163.0%)
-$133.91M(-281.4%)
Sep 2001
-
-$7.59M(+81.8%)
-$35.11M(-42.6%)
Jun 2001
-
-$41.59M(-474.8%)
-$24.62M(-129.0%)
Mar 2001
-
$11.10M(+273.6%)
-$10.75M(-591.7%)
Dec 2000
-$1.55M(+97.7%)
$2.97M(+2.3%)
-$1.55M(+85.3%)
Sep 2000
-
$2.90M(+110.5%)
-$10.61M(+83.0%)
Jun 2000
-
-$27.72M(-236.6%)
-$62.27M(-33.2%)
Mar 2000
-
$20.29M(+433.7%)
-$46.76M(+32.0%)
Dec 1999
-$68.75M(-739.3%)
-$6.08M(+87.5%)
-$68.75M(-9.7%)
Sep 1999
-
-$48.76M(-299.5%)
-$62.67M(-350.7%)
Jun 1999
-
-$12.20M(-617.5%)
-$13.91M(-717.5%)
Mar 1999
-
-$1.70M
-$1.70M
Dec 1998
-$8.19M(-679.2%)
-
-
Dec 1997
-$1.05M
-
-

FAQ

  • What is BioMarin Pharmaceutical Inc. annual cash from investing?
  • What is the all-time high annual cash from investing for BioMarin Pharmaceutical Inc.?
  • What is BioMarin Pharmaceutical Inc. annual cash from investing year-on-year change?
  • What is BioMarin Pharmaceutical Inc. quarterly cash from investing?
  • What is the all-time high quarterly cash from investing for BioMarin Pharmaceutical Inc.?
  • What is BioMarin Pharmaceutical Inc. quarterly cash from investing year-on-year change?
  • What is BioMarin Pharmaceutical Inc. TTM cash from investing?
  • What is the all-time high TTM cash from investing for BioMarin Pharmaceutical Inc.?
  • What is BioMarin Pharmaceutical Inc. TTM cash from investing year-on-year change?

What is BioMarin Pharmaceutical Inc. annual cash from investing?

The current annual cash from investing of BMRN is $136.49M

What is the all-time high annual cash from investing for BioMarin Pharmaceutical Inc.?

BioMarin Pharmaceutical Inc. all-time high annual cash from investing is $264.35M

What is BioMarin Pharmaceutical Inc. annual cash from investing year-on-year change?

Over the past year, BMRN annual cash from investing has changed by +$247.74M (+222.70%)

What is BioMarin Pharmaceutical Inc. quarterly cash from investing?

The current quarterly cash from investing of BMRN is -$12.59M

What is the all-time high quarterly cash from investing for BioMarin Pharmaceutical Inc.?

BioMarin Pharmaceutical Inc. all-time high quarterly cash from investing is $461.25M

What is BioMarin Pharmaceutical Inc. quarterly cash from investing year-on-year change?

Over the past year, BMRN quarterly cash from investing has changed by -$103.07M (-113.92%)

What is BioMarin Pharmaceutical Inc. TTM cash from investing?

The current TTM cash from investing of BMRN is $19.42M

What is the all-time high TTM cash from investing for BioMarin Pharmaceutical Inc.?

BioMarin Pharmaceutical Inc. all-time high TTM cash from investing is $474.86M

What is BioMarin Pharmaceutical Inc. TTM cash from investing year-on-year change?

Over the past year, BMRN TTM cash from investing has changed by +$53.94M (+156.25%)
On this page